Latest · Guide
Starting Oral GLP-1s: A Practical First-30-Days Guide
What to actually expect in your first 30 days on oral GLP-1s — a practical day-by-day guide for new patients.
What to actually expect in your first 30 days on oral GLP-1s — a practical day-by-day guide for new patients.
How oral GLP-1 therapy affects sleep quality — the typical 90-day pattern and what to do if sleep worsens.
Setting up your at-home oral tirzepatide routine — the practical guide from unboxing to daily rhythm.
The fasting protocol for oral semaglutide — why it matters, what happens when you don't follow it, and how strict to be.
The slow-titration playbook for oral GLP-1 patients who don't tolerate standard escalation.
The common oral GLP-1 side effects and practical strategies for managing each — nausea, constipation, fatigue, and more.
How oral GLP-1 therapy affects exercise capacity, recovery, and the adjustments patients typically need to make.
The medication interaction check for patients taking oral GLP-1s — what to review with your prescriber before combining.
Oral GLP-1s and caffeine — what coffee does to absorption, response, and daily practical patterns.
The oral GLP-1 and alcohol question — what patients need to know about combining GLP-1 therapy with alcohol consumption.
The case for oral GLP-1s for patients with needle phobia — how the format addresses a real barrier to injectable therapy.
The complete nausea management guide for oral GLP-1 patients — prevention, treatment, and when to consider a treatment pause.
Meal timing and food choices while on oral GLP-1s — practical guidance for eating patterns that work with the medication.
What long-term oral GLP-1 use actually looks like beyond the first year — patterns in year 2, year 3, and beyond.
The hydration approach that supports oral GLP-1 therapy — why details matter for symptom management and overall wellbeing.
The real evidence on switching from an injectable GLP-1 to an oral one — what the ATTAIN-MAINTAIN trial actually showed, and why the calculus differs for compounded oral options.
The Wegovy pill's $149/mo entry price puts it near compounded oral GLP-1 territory. Here's whether the extra evidence behind it is worth paying for at every price tier.
No FDA-approved oral tirzepatide exists in 2026. Here's who sells a compounded version, what it costs, and the molecular-weight problem every provider has to work around.
Every oral semaglutide price we track in July 2026 — from $99/mo compounded sublingual programs to $349/mo brand-name Foundayo — compared side by side.
OASIS, ATTAIN, STEP, and SURMOUNT trial data compared head to head — the real efficacy gap between oral and injectable GLP-1s, with exact trial numbers and estimands.
Six oral GLP-1 providers with pricing under $200/month in July 2026 — compared on format, dosing, and the fine print that changes what you actually pay.
How oral GLP-1 side effect and discontinuation rates actually compare to injectable pens, using published trial data from OASIS, ATTAIN-1, STEP, and SURMOUNT.
Sublingual drops, dissolvable tablets, capsules, gummies, SNAC-enabled pills — every oral GLP-1 format explained, with the absorption science behind each and who sells what.
Oral GLP-1s work the same way in men as in women — but needle aversion, testosterone effects, and how the hormonal research applies specifically to the oral route are worth understanding…
The real first-month discounts, dose-tiered introductory pricing, and insurance-based savings currently available across oral GLP-1 providers — no invented promo codes, just what's actually…
How oral GLP-1s interact with levothyroxine, warfarin, birth control, insulin, and other common medications — grounded in published pharmacokinetic research, with an oral-specific timing…
The actual science behind oral GLP-1 absorption: how SNAC technology gets semaglutide past the stomach, why sublingual drops face a much harder problem, and how Foundayo sidesteps the issue…
Gummies and sublingual drops are the most consumer-friendly compounded oral GLP-1 formats — but do they actually work? Here's the honest science and who sells them.
Foundayo, the Wegovy pill, and compounded oral GLP-1s compared: trial data, dosing rules, pricing, and how to decide which oral route actually fits your situation.
Everything worth knowing about Foundayo (orforglipron), Eli Lilly's oral GLP-1 approved in April 2026 — the trial data, the pricing tiers, and why it skips the food and water rules other…
A timeline of FDA enforcement actions against compounded GLP-1 telehealth companies through 2025–2026, including the MEDVi warning letter and the Hims & Hers compounded oral pill saga.
A complete July 2026 breakdown of every oral GLP-1 option: the 3 FDA-approved pills, plus 12 compounded sublingual, tablet, and gummy providers — prices and formats compared.
What FDA approval actually means for a GLP-1 medication, why compounded oral versions aren't a legal gray area but a specific regulatory carve-out, and where that carve-out currently stands…
The lowest-priced oral GLP-1 programs in July 2026, and how to tell a legitimately cheap option from a red flag before you hand over your payment info.
Needle phobia keeps a meaningful share of adults away from injectable GLP-1s entirely. Here's every no-injection oral option, honestly compared, for patients who want the benefits without…